The attachment of microorganisms to biological surfaces is a complex process which often involves "lock and key"-type interactions between lectinlike bacterial attachment proteins (adhesins) and complex carbohydrate receptors on host tissues (5) . Many gram-negative bacteria express filamentous nonflagellar surface appendages, known as pili or fimbriae, which are responsible for mediating these interactions (16, 19) . Pili are composed of alpha-helical arrays of proteinaceous subunits called pilin. The adhesive properties of pili may be associated with the pilin molecules themselves or with other pilus-associated proteins (1, 24, 27, 30, 33) .
Many Escherichia coli strains appear to attach to a variety of eucaryotic cell surfaces by the interaction of an adhesin associated with type 1 (common) pili and mannose-containing glycoproteins (34, 36) . This phenomenon is readily demonstrated by the ability of type 1-piliated organisms to agglutinate guinea pig erythrocytes or yeast cells, a process inhibited by mannose or mannoside derivatives (40; mannose-sensitive hemagglutination reaction). Alternately, many pathogenic gram-negative organisms express adhesins which recognize sugar groups other than mannose on host tissue surfaces and, in many cases, are responsible for the agglutination of erythrocytes from a variety of species in the presence of mannose or its analogs (mannose-resistant hemagglutination reaction; 13, 16) .
Enterotoxigenic E. coli produces diarrheal disease in humans by colonizing the mucosal surface of the small bowel, where the organisms express at least one and sometimes two plasmid-encoded enterotoxins (12, 16, 17) . The colonization process is mediated by adhesins which are also often involved in mannose-resistant hemagglutination (13) . The attachment of one of the enterotoxigenic E. coli strains, H10407, to human erythrocytes and intestinal epithelial cells * Corresponding author.
is mediated by colonization factor antigen I (CFA/I) pili (7, 8, (20) (21) (22) .
Although the role of CFA/I pili in attachment to intestinal cells and erythrocytes is thoroughly documented, the receptors involved in these interactions have not been conclusively identified, and, unlike other pilus systems (1, 24, 27, 30, 33) , the location of the CFA/I receptor binding domain has not been established. Previously, it was suggested that sialic acid-containing ganglioside GM2 was the erythrocyte receptor for CFA/I pili (14, 26) , but sialoglycoproteins have also been implicated (4) . In addition, the relationship between the erythrocyte and intestinal receptors for CFA/I pili is uncertain because hemagglutination does not occur at 37°C (16) . This observation suggests that CFA/I pili contain either (i) two independent receptor binding domains, on one or more adhesins, which strictly recognize different receptors on intestinal cells and erythrocytes; or (ii) one binding site which recognizes, with different affinity, more than one receptor. It is important to distinguish between these possibilities to develop a rational approach to immunoprophylaxis based on synthetic peptides representing CFA/I pilus receptor binding domains or novel pharmacologic compounds designed to block pilus-receptor interactions in the infected nonimmunized host. Therefore, the purpose of the present study was to identify a CFA/I receptor(s) in human erythrocyte membranes to further investigate the lectinlike properties of CFA/I pili.
MATERIALS AND METHODS
Characterization of bacterial strains. Enterotoxigenic E. coli strains H10407 (078:H11; CFA/I+) and H10407P (078:
Hil; CFA/I-) were kindly provided by M. C. Finlayson (Provincial Laboratory of Alberta, Edmonton, Alberta, Canada), who originally obtained them from D. G. Evans . Both strains were grown on CFA/I agar as described previously (11) to obtain maximum production of CFAII pili in the CFA/I+ strain and repress the production of type 1 pili in both the CFA/I+ and CFA/I-strains (11, 20) . The presence of the 59-to 61-megadalton plasmid, which contains the genes encoding CFA/I pili (41) , was confirmed by agarose gel electrophoresis following the alkaline extraction procedure devised by Birnboim and Doly (6 Preparation of purified CFA/I pili. CFA/I pili were purified by the procedure described previously (2) . The quality of the purified pili preparations was determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and electron microscopic examination. Pili preparations were considered to be pure when only one band could be detected in Coomassie blue-stained SDS-polyacrylamide gels and no flagella (the major contaminant) could be detected by either electron microscopy or SDS-PAGE techniques.
Extraction of human erythrocyte membranes with lithium diiodosalicylate. The glycoprotein fraction from human erythrocyte membranes was prepared by the lithium diiodosalicylate extraction procedure described previously (29) . The concentration of protein in-the extracts was determined by the procedure of Lowry et al. (28) . lodination procedure. Purified CFA/I pili or the erythrocyte extracts were labeled by the conventional iodination procedure described previously (3, 42) . counts incorporated into protein was determined by trichloroacetic acid precipitation as described previously (3) to calculate the specific activity. A 200-pdl portion of PBS containing 0.1% bovine serum albumin was then added to the mixture to prevent nonspecific binding to Sephadex.
Next, to separate 125I-labeled proteins from free iodine, the mixture was passed through a disposable Sephadex G25 column (1 by 10 cm; Pharmacia P-L Biochemicals, Inc., Dorval, Quebec) equilibrated with PBS-0.1% bovine serum albumin. Sixteen 0.5-ml fractions were collected from the column, and 10-,u aliquots of each fraction were counted in an LKB Rackgamma II 1270 gamma counter (counting efficiency, 50% for 1251) to determine the location of the void volume fractions containing labeled protein. In a typical experiment, 1.5 ml contained approximately 4 ,ug of iodinated protein (>80% trichloroacetic acid precipitable).
Identification of CFA/I receptor in 251-labeled erythrocyte extracts. Bacteria grown on CFA/I agar were suspended in distilled H20 and examined for the presence of pili by the procedures described earlier. One milliliter of bacterial suspension (3 x 10' to 5. x 108 cells) was mixed with approximately 106 cpm of 125I-labeled extract and incubated at ambient temperature for 1 h in the presence or absence of excess purified CFA/I pili. The bacteria were then sedimented by centrifugation for 2 min at 5,000 x g. The supernatant solutions were discarded, the bacterial pellets were suspended in 1 ml of H20, and the centrifugation procedure was repeated. The resulting bacterial pellets were then solubilized in the sample buffer described by Laemmli (25) and analyzed by discontinuous SDS-PAGE in the presence of P-mercaptoethanol as described earlier (35) . After electrophoretic separation of the labeled extract components, the gels were fixed and stained with Coomassie blue to establish the positions of the molecular weight marker proteins. The fixed stained gels were then dried under reduced pressure on a slab gel drier (model 1125B; Bio-Rad Laboratories, Richmond, Calif.) and exposed for 48 to 72 h at -70°C to Kodak X-OMAT RP film, using Cronex Lightning-Plus intensifying screens (Du Pont Co., Wilmington, Del.). Densitometric analysis of the autoradiograms was VOL. 56, 1988 on November 6, 2017 by guest http://iai.asm.org/ Downloaded from performed on a Chromoscan 3 densitometer (Joyce-Loebl Co., Gates Head'ne, U.K.).
Wheat germ agglutinin affinity chromatography of iodinated erythrocyte extract. Affinity chromatography of iodinated extract preparations was performed in glass-wool-plugged Pasteur pipettes containing approximately 0.4 ml of wheat germ agglutinin-agarose (Pharmacia P-L Biochemicals) equilibrated with 50 mM sodium phosphate buffer (pH 7.2) containing 0.5 M NaCI, 1 mM MgCl2, 1 mM CaC12, and 1.0% bovine serum albumin (column buffer). All steps were performed at room temperature. The iodinated extract was diluted in column buffer, and 200 ,ul was applied to the columns. This solution was allowed to bind to the affinity matrix for 2 h, and the unbound material was washed out with 8 ml of column buffer. Bound glycoproteins were eluted with 8 ml of 0.5 M N-acetylglucosamine. Fractions of 0.5 ml were collected during the washing and elution steps. Aliquots of the peak fractions were analyzed by SDS-PAGE.
RESULTS
On examination by SDS-PAGE, the purified CFA/I pili produced only one band with an apparent molecular weight of 15,000 + 800 (n = 5; Fig. 1 ). This was in good agreement with the 14,500 value calculated from the published amino acid sequence for the CFA/I pilin subunit (18) . In addition, although the H10407 CFA/I+ strain used in this study was judged to be free of type 1 pili by the absence of a guinea pig mannose-sensitive hemagglutination reaction, SDS-PAGE also indicated that the strains did not produce type 1 pili because we did not observe a protein band with a molecular weight of 17 ,000 (molecular weight of type 1 pilin by SDS-PAGE procedures [9, 31] ) or high-molecular-weight type 1 pilin aggregates in our CFA/I pili preparations (Fig. 1) CFA/1-+ Pili 13.3 ± 4.9 +1.3 ± 8.8
" Binding assays were performed in the presence or absence of 0.7 mg of purified CFA/I pili per ml as described in Materials and Methods. Each value represents the mean of six independent determinations. The difference in attachment of CFA/I+ bacteria in the presence and absence of CFA/I pili was found to be statistically significant (P < 0.01, Student t test). The difference in the attachment of CFA/1-bacteria in the presence or absence of CFA/I pili was found to be statistically insignificant (P > 0.2). moieties on the erythrocyte surface, and a second mechanism not causing hemagglutination which was shared by CFA/I+ and CFA/I-bacteria.
To further investigate the nature of the receptor, wholeorganism binding experiments were performed with trypsinor neuraminidase-treated erythrocytes. The data presented in Table 2 suggested that the binding domain for CFA/I pili on the erythrocyte membrane is a glycoprotein containing important sialic acid residues. This result was consistent with the earlier findings of Bartus et al. (4) . However, in the earlier studies, the identity of the glycoprotein receptor was not established.
Therefore, to explore the nature of the CFA/I receptor further, we prepared glycoprotein extracts of the erythrocyte membranes as described previously (29) . The extracts caused the agglutination of CFA/I+ but not CFA/1-organisms at a protein concentration of 0.5 mg/ml in a slide agglutination test. This suggested an interaction between components in the extract and CFA/I pili. To identify CFA/I receptor species in the extracts, we performed an affinity isolation procedure, using 125I-labeled erythrocyte extract and CFA/I+ and CFA/I-bacteria. In densitometric scans of the SDS-PAGE gel autoradiograms (Fig. 2b) , the areas of the 38,000-, 30,000-, and 17,000-molecular-weight peaks in the CFA/I-lane were 41 + 31, 76 ± 16, and 115 ± 65% (n = 3), respectively, of the areas of the same peaks in the CFA/II lane. The CFA/I+-specific, 26,000-molecular-weight receptor moiety indicated in Fig. 2a was never observed in the CFA/1-lane. Additional evidence for the specificity of the 26,000-molecular-weight band for CFA/I pili was obtained by demonstrating that purified CFA/I pili were able to CFA/I-12.1 ± 1.0 "The binding assay was performed as described in Materials and Methods.
Prior to binding, human erythrocytes in PBS were incubated for 30 min with trypsin (1 mg/ml) or neuraminidase (1 ,ug/ml) at 37'C. After treatment, the erythrocytes were washed by centrifugation to remove the enzymes. The difference in CFA/I+ binding to treated and untreated cells was significant (P < 0.01). All other differences were insignificant (P > 0.2). compete for their binding to CFA/1' organisms ( Fig. 2A) .
Moreover, the 26,000-molecular-weight species was also observed to bind to wheat germ agglutinin affinity columns (Fig. 3) . This finding suggested that the CFAII receptor identified by the affinity isolation procedure was a glycoprotein containing sialyloligosaccharide units (23) . This was consistent with the binding experiment results presented in Tables 1 and 2 .
Although high-molecular-weight iodinated mnaterial which failed to enter the separating gels was also detec'ted only in lanes containing CFA/1-bound extract components, it remains to be determined whether this represents aggregates of the 26,000-molecular-weight CFA/1-specific species or a unique erythrocyte receptor.
DISCUSSION
The objective of the present study was to identify erythrocyte receptors for CFA/I pili. When (44) . However, trypsin treatment does not remove sialic acid-containing glycopeptides associated with the extracellular domain of band 3 (43) . The removal of sialic acid groups by neuraminidase treatment would also result in a decrease in the surface negativity of erythrocytes, but with less selectivity than trypsid treatment. If the CFA/I-organisms were binding to erythrocytes through ionic or hydrophobic mechanisms (theory ii, above), then the alteration in erythrocyte surface charge by the trypsin or neuraminidase treatments should have resulted in a change in CFA/1-binding to erythrocytes, and this was not observed ( Table 2 ). The removal of mannose-containing glycoproteins should also have resulted in a decrease in attachment if binding were due to type 1 pili (theory iii, above), an unlikely event in any case because the growth of H10407 bacteria on CFA/I agar supresses the production of their type 1 pili (11, 20) .
In the present report, we have demnonstrated that sialic acid groups on glycoproteins are important for the interaction of CFA/I pili with erythrocyte receptors. However, sialic acid is a common component ofmany glycoprotein and ganglioside oligosaccharide units (32) . This may be the reason why the identity of CFA/I receptors remains controversial. Even though it may be possible to show by studies, such as those we describe here, that they recognize particular sugar groups in complex glycoconjugates, pili are able to demonstrate a considerable range of affinities for such groups in the context of oligosaccharide structures containing different sugar sequencds (34) . It is possible that CFA/I pili, like type 1 pili (34) , recognize many related sialic acid-containing glycoconjugates but with different affinities. The procedure we have developed here has allowed us to identify a receptor in a mixture of glycoproteins extracted from erythrocyte membranes. Moreover, the iodinated receptor appeared to retain its ability to bind to CFA/I+ organisms with a high enough affinity to remain bound during the removal of unbound labeled extract components. This suggested that the failure of the competitive binding assay that uses iodinated CFA/I pili, as discussed earlier, was a result of iodination damage to the receptor binding site of CFA/I pili and not the result of low-affinity binding. Oligosaccharide receptors appear to be resistant to iodination damage. For example, when pertussis toxin is iodinated by conventional procedures, its binding to fetuin is greatly diminished (3) . However, even if fetuin is iodinated under fairly harsh conditions, the iodinated fetuin binds well to pertussis toxin (39) .
Although conventional iodination reactions destroy its ability to recognize receptors, the functional integrity of pertussis toxin's receptor binding sites could be protected if the iodination reaction was performed when the binding sites were occupied (3). The binding domains for CFA/I intestinal and erythrocyte receptors both appear to be located at the pilus tips (21 
